{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10704251", "DateCompleted": {"Year": "2000", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2016", "Month": "11", "Day": "24"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1043-4666", "JournalIssue": {"Volume": "12", "Issue": "3", "PubDate": {"Year": "2000", "Month": "Mar"}}, "Title": "Cytokine", "ISOAbbreviation": "Cytokine"}, "ArticleTitle": "Sesquiterpene lactones are potent inhibitors of interleukin 8 gene expression in cultured human respiratory epithelium.", "Pagination": {"StartPage": "239", "EndPage": "245", "MedlinePgn": "239-45"}, "Abstract": {"AbstractText": ["Sesquiterpene lactones, derived from Mexican-Indian medicinal plants, are known to have potent anti-inflammatory properties but the mechanisms of this effect are not completely understood. Recent data demonstrated that sesquiterpene lactones were potent inhibitors of the pro-inflammatory transcription factor NF-kappaB. Because activation of NF-kappaB is involved in the regulation of the chemokine interleukin 8 (IL-8), we hypothesized that the sesquiterpene lactones, isohelenin and parthenolide, would inhibit IL-8 gene expression in cultured human respiratory epithelium. Incubating A549 cells with tumour necrosis factor alpha (TNF-alpha) induced IL-8 mRNA expression and secretion of immunoreactive IL-8. Pretreatment with either isohelenin or parthenolide inhibited TNF-alpha-mediated IL-8 gene expression in a concentration-dependent manner. Pretreatment with either compound inhibited TNF-alpha mediated activation of the IL-8 promoter and TNF-alpha-mediated nuclear translocation of NF-kappaB. In addition, pretreatment with isohelenin or parthenolide inhibited TNF-alpha-mediated degradation of the NF-kappaB inhibitory protein, I-kappaBalpha. We conclude that sesquiterpene lactones are potent in vitro inhibitors of IL-8 gene expression in cultured human respiratory epithelium. The most proximal mechanism of inhibition appears to involve inhibition of I-kappaBalpha degradation. Stabilization of cytoplasmic I-kappaBalpha leads to inhibition of NF-kappaB nuclear translocation and of subsequent IL-8 promoter activation. The ability of sesquiterpene lactones to modulate IL-8 gene expression may explain, in part, their anti-inflammatory effects."], "CopyrightInformation": "Copyright 2000 Academic Press."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Divisions of Critical Care Medicine and Pulmonary Medicine, Children's Hospital Research Foundation, Cincinnati, Ohio, USA."}], "Identifier": [], "LastName": "Mazor", "ForeName": "R L", "Initials": "RL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Menendez", "ForeName": "I Y", "Initials": "IY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ryan", "ForeName": "M A", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fiedler", "ForeName": "M A", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wong", "ForeName": "H R", "Initials": "HR"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cytokine", "NlmUniqueID": "9005353", "ISSNLinking": "1043-4666"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NFKBIA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "isohelenin"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "2RDB26I5ZB", "NameOfSubstance": "parthenolide"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Biological Transport"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Epithelium"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": ["genetics"], "DescriptorName": "Interleukin-8"}, {"QualifierName": ["cytology", "immunology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "3", "Day": "8", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "4", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "3", "Day": "8", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10704251", "10.1006/cyto.1999.0526", "S1043-4666(99)90526-4"]}}], "PubmedBookArticle": []}